Assembly Biosciences Inc. (ASMB) NASDAQ
$13.41 0.08 (0.60%)
Market Cap: $73.09M
As of 04/19/24 04:30 PM EDT. Market closed.
Assembly Biosciences Inc. (ASMB)
NASDAQ
$13.41
0.08 (0.60%)
Market Cap: $73.09M
As of 04/19/24 04:30 PM EDT. Market closed.
Add to Portfolio
assembly biosciences, inc. (nasdaq: asmb) is a public clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis b virus (hbv) infection and novel oral live biotherapeutics for disorders associated with the microbiome. assembly is developing two innovative platform programs: an hbv program advancing a new class of oral therapeutics for the ... read more
assembly biosciences, inc. (nasdaq: asmb) is a public clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis b virus (hbv) infection and novel oral live biotherapeutics for disorders associated with the microbiome. assembly is developing two innovative platform programs: an hbv program advancing a new class of oral therapeutics for the treatment of hepatitis b virus (hbv) infection and a microbiome program developing novel oral live biotherapeutics designed to address diseases associated with the microbiome. assembly’s hbv program is advancing multiple drug candidates with the aim of increasing cure rates in patients with chronic hbv. the company's microbiome program consists of a fully integrated platform that includes a robust strain identification and selection process, methods for strain isolation and growth under current good manufacturing practices and a patent-pending delivery system, gemicel®, which allows for targeted ora read less
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO Compensation (Base)
$516,667
CEO Compensation (Total)
$4.75M
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
110
CEO Compensation (Base)
$516,667
CEO Compensation (Total)
$4.75M
Address
.
PRICE CHART FOR ASSEMBLY BIOSCIENCES INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$13.69
Previous Close
$13.33
Days Range
$13.24 - $13.90
52 week range
$7.69 - $20.04
Volume
11,396
Avg. Volume (30 days)
21,780
Market Cap
$73.09M
Dividend Yield
-
P/E
-
Shares Outstanding
5,482,752
Open
$13.69
Previous Close
$13.33
Days Range
$13.24 - $13.90
52 week range
$7.69 - $20.04
Volume
11,396
Avg. Volume (30 days)
21,780
Market Cap
$73.09M
Dividend Yield
-
P/E
-
Shares Outstanding
5,482,752
FINANCIAL STATEMENTS FOR ASSEMBLY BIOSCIENCES INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR ASSEMBLY BIOSCIENCES INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| McHutchison John G | Director | Apr 01, 2024 | Sale | $13.07 | 1,206 | 15,765 | 21,221 | Apr 02, 2024, 04:25 PM |
| White Nicole S | Chief Manufacturing Officer | Apr 01, 2024 | Sale | $13.07 | 197 | 2,575 | 10,947 | Apr 02, 2024, 04:15 PM |
| Okazaki Jason A | CEO and President | Apr 01, 2024 | Sale | $13.07 | 354 | 4,627 | 13,826 | Apr 02, 2024, 04:05 PM |
| Okazaki Jason A | CEO and President | Mar 27, 2024 | Sale | $12.87 | 392 | 5,045 | 14,180 | Mar 29, 2024, 04:05 PM |
| Schornstein Alexander | 10% Owner | Jan 17, 2024 | Buy | $0.78 | 299,994 | 235,195 | 7,864,286 | Jan 19, 2024, 11:01 AM |
| Schornstein Alexander | 10% Owner | Jan 18, 2024 | Buy | $0.80 | 345,086 | 276,069 | 8,209,372 | Jan 19, 2024, 11:01 AM |
| Schornstein Alexander | 10% Owner | Nov 21, 2023 | Buy | $0.67 | 100,000 | 66,700 | 7,564,292 | Nov 22, 2023, 04:10 PM |
| Schornstein Alexander | 10% Owner | Nov 20, 2023 | Buy | $0.72 | 300,000 | 215,400 | 7,464,292 | Nov 22, 2023, 04:10 PM |
| White Nicole S | Chief Manufacturing Officer | Nov 17, 2023 | Sale | $0.69 | 477 | 329 | 93,774 | Nov 21, 2023, 04:05 PM |
| White Nicole S | Chief Manufacturing Officer | Oct 03, 2023 | Sale | $0.80 | 1,891 | 1,504 | 94,251 | Oct 04, 2023, 04:15 PM |
| Delaney William E IV | Chief Scientific Officer | Oct 03, 2023 | Sale | $0.80 | 1,891 | 1,504 | 150,853 | Oct 04, 2023, 04:10 PM |
| Okazaki Jason A | CEO and President | Oct 03, 2023 | Sale | $0.80 | 2,363 | 1,879 | 174,923 | Oct 04, 2023, 04:05 PM |
| Delaney William E IV | Chief Scientific Officer | Aug 02, 2023 | Sale | $1.09 | 9,461 | 10,293 | 142,744 | Aug 03, 2023, 04:10 PM |
| Okazaki Jason A | CEO and President | Aug 02, 2023 | Sale | $1.09 | 11,827 | 12,867 | 164,786 | Aug 03, 2023, 04:05 PM |
| Bjorkquist Jeanette M | Principal Accounting Officer | Jul 24, 2023 | Sale | $1.07 | 844 | 900 | 26,688 | Jul 25, 2023, 04:30 PM |
| Delaney William E IV | Chief Scientific Officer | May 30, 2023 | Sale | $0.96 | 4,232 | 4,046 | 112,205 | May 31, 2023, 04:05 PM |
| McHutchison John G | Director | May 23, 2023 | Sale | $1.04 | 25,972 | 27,019 | 169,160 | May 24, 2023, 05:15 PM |
| Bjorkquist Jeanette M | Principal Accounting Officer | May 23, 2023 | Sale | $1.04 | 274 | 285 | 27,532 | May 24, 2023, 05:10 PM |
| Delaney William E IV | Chief Scientific Officer | May 23, 2023 | Sale | $1.04 | 6,561 | 6,825 | 116,437 | May 24, 2023, 05:05 PM |
| Okazaki Jason A | CEO and President | May 23, 2023 | Sale | $1.04 | 6,561 | 6,825 | 126,613 | May 24, 2023, 05:00 PM |
| McHutchison John G | Director | Mar 30, 2023 | Sale | $0.82 | 14,883 | 12,252 | 177,632 | Mar 31, 2023, 04:45 PM |
| Bjorkquist Jeanette M | Principal Accounting Officer | Mar 30, 2023 | Sale | $0.82 | 774 | 637 | 23,806 | Mar 31, 2023, 04:40 PM |
| Delaney William E IV | Chief Scientific Officer | Mar 30, 2023 | Sale | $0.82 | 3,421 | 2,816 | 85,498 | Mar 31, 2023, 04:35 PM |
| Okazaki Jason A | CEO and President | Mar 30, 2023 | Sale | $0.82 | 4,247 | 3,496 | 98,174 | Mar 31, 2023, 04:30 PM |
| Okazaki Jason A | CEO and President | Mar 27, 2023 | Sale | $1.02 | 4,693 | 4,785 | 102,421 | Mar 28, 2023, 04:05 PM |
| McHutchison John G | Chief Executive Officer | Aug 08, 2022 | Sale | $2.13 | 12,314 | 26,200 | 192,515 | Aug 10, 2022, 05:00 PM |
| Samar Michael P. | Chief Financial Officer | Jul 25, 2022 | Sale | $2.22 | 2,020 | 4,479 | 77,228 | Jul 26, 2022, 05:00 PM |
| Delaney William E IV | Chief Scientific Officer | May 31, 2022 | Sale | $1.92 | 4,164 | 8,005 | 76,419 | Jun 02, 2022, 05:00 PM |
| Samar Michael P. | Chief Financial Officer | Mar 30, 2022 | Sale | $2.17 | 2,285 | 4,953 | 76,748 | Mar 31, 2022, 04:52 PM |
| Stamm Luisa M | Chief Medical Officer | Mar 30, 2022 | Sale | $2.17 | 1,038 | 2,250 | 40,315 | Mar 31, 2022, 04:48 PM |
| Delaney William E IV | Chief Scientific Officer | Mar 30, 2022 | Sale | $2.17 | 1,038 | 2,250 | 78,083 | Mar 31, 2022, 04:44 PM |
| Okazaki Jason A | Chief Operating Officer | Mar 30, 2022 | Sale | $2.17 | 1,269 | 2,750 | 94,614 | Mar 31, 2022, 04:41 PM |
| McHutchison John G | CEO and President | Mar 30, 2022 | Sale | $2.17 | 4,614 | 10,000 | 204,829 | Mar 31, 2022, 04:36 PM |
| Okazaki Jason A | Chief Operating Officer | Mar 28, 2022 | Sale | $2.24 | 4,617 | 10,363 | 64,633 | Mar 29, 2022, 07:33 PM |
| McHutchison John G | CEO and President | Aug 09, 2021 | Sale | $3.60 | 12,156 | 43,781 | 125,693 | Aug 10, 2021, 05:09 PM |
| Papkoff Jacqueline Sybil | SVP-CSO Microbiome | Dec 14, 2020 | Sale | $6.15 | 1,297 | 7,983 | 37,364 | Dec 15, 2020, 09:18 PM |
| Stamm Luisa M | Chief Medical Officer | Nov 09, 2020 | Sale | $5.10 | 4,397 | 22,404 | 7,603 | Nov 10, 2020, 07:28 PM |
| McHutchison John G | CEO and President | Aug 07, 2020 | Sale | $21.80 | 12,151 | 264,917 | 138,605 | Aug 10, 2020, 04:34 PM |
| Papkoff Jacqueline Sybil | SVP-CSO Microbiome | Mar 30, 2020 | Sale | $14.22 | 1,254 | 17,831 | 38,661 | Mar 31, 2020, 04:16 PM |
| Colonno Richard James | EVP & CSO, Virology Ops | Mar 31, 2020 | Sale | $15.04 | 7,812 | 117,524 | 137,009 | Mar 31, 2020, 04:15 PM |
| Papkoff Jacqueline Sybil | SVP-CSO Microbiome | Dec 13, 2019 | Sale | $21.00 | 1,460 | 30,662 | 22,915 | Dec 16, 2019, 05:21 PM |
| Colonno Richard James | EVP & CSO, Virology Ops | Dec 12, 2019 | Option Exercise | $7.03 | 33,061 | 232,419 | 160,882 | Dec 16, 2019, 05:17 PM |
| Colonno Richard James | EVP & CSO, Virology Ops | Dec 12, 2019 | Sale | $25.00 | 33,061 | 826,578 | 127,821 | Dec 16, 2019, 05:17 PM |
| Lopatin Uri A | Chief Med. Off., VP Res. Dev. | Sep 06, 2018 | Sale | $40.01 | 336 | 13,442 | 613,611 | Sep 07, 2018, 04:44 PM |
| Lopatin Uri A | Chief Med. Off., VP Res. Dev. | Sep 05, 2018 | Sale | $40.09 | 15,204 | 609,547 | 613,947 | Sep 07, 2018, 04:44 PM |
| Small Derek A | CEO and President | Jul 19, 2018 | Buy | $41.48 | 2,400 | 99,551 | 669,291 | Jul 20, 2018, 04:01 PM |
| RINGO WILLIAM R | Director | Jul 02, 2018 | Option Exercise | $7.20 | 1,000 | 7,200 | 20,465 | Jul 03, 2018, 12:00 AM |
| RINGO WILLIAM R | Director | Jul 02, 2018 | Sale | $38.50 | 1,000 | 38,503 | 19,465 | Jul 03, 2018, 12:00 AM |
| RINGO WILLIAM R | Director | Jun 01, 2018 | Option Exercise | $7.20 | 1,000 | 7,200 | 20,465 | Jun 01, 2018, 05:54 PM |
| RINGO WILLIAM R | Director | Jun 01, 2018 | Sale | $42.47 | 1,000 | 42,470 | 19,465 | Jun 01, 2018, 05:54 PM |
| RINGO WILLIAM R | Director | May 01, 2018 | Option Exercise | $7.20 | 1,000 | 7,200 | 20,465 | May 02, 2018, 04:05 PM |
| RINGO WILLIAM R | Director | May 01, 2018 | Sale | $43.06 | 1,000 | 43,060 | 19,465 | May 02, 2018, 04:05 PM |
| RINGO WILLIAM R | Director | Apr 02, 2018 | Option Exercise | $7.20 | 1,000 | 7,200 | 20,465 | Apr 02, 2018, 06:07 PM |
| RINGO WILLIAM R | Director | Apr 02, 2018 | Sale | $49.32 | 1,000 | 49,320 | 19,465 | Apr 02, 2018, 06:07 PM |
| RINGO WILLIAM R | Director | Mar 01, 2018 | Option Exercise | $7.20 | 1,000 | 7,200 | 20,465 | Mar 02, 2018, 12:00 AM |
| RINGO WILLIAM R | Director | Mar 01, 2018 | Sale | $56.37 | 1,000 | 56,370 | 19,465 | Mar 02, 2018, 12:00 AM |
| RINGO WILLIAM R | Director | Feb 01, 2018 | Option Exercise | $7.20 | 1,000 | 7,200 | 20,465 | Feb 02, 2018, 04:05 PM |
| RINGO WILLIAM R | Director | Feb 01, 2018 | Sale | $46.86 | 1,000 | 46,860 | 19,465 | Feb 02, 2018, 04:05 PM |
| RINGO WILLIAM R | Director | Jan 02, 2018 | Option Exercise | $7.20 | 1,000 | 7,200 | 20,465 | Jan 03, 2018, 04:30 PM |
| RINGO WILLIAM R | Director | Jan 02, 2018 | Sale | $45.04 | 1,000 | 45,040 | 19,465 | Jan 03, 2018, 04:30 PM |
| RINGO WILLIAM R | Director | Dec 01, 2017 | Option Exercise | $7.20 | 1,000 | 7,200 | 20,465 | Dec 04, 2017, 04:05 PM |
| RINGO WILLIAM R | Director | Dec 01, 2017 | Sale | $49.37 | 1,000 | 49,370 | 19,465 | Dec 04, 2017, 04:05 PM |
| RINGO WILLIAM R | Director | Nov 01, 2017 | Option Exercise | $7.20 | 1,000 | 7,200 | 20,465 | Nov 03, 2017, 05:15 PM |
| RINGO WILLIAM R | Director | Nov 01, 2017 | Sale | $29.55 | 1,000 | 29,550 | 19,465 | Nov 03, 2017, 05:15 PM |
| RINGO WILLIAM R | Director | Oct 16, 2017 | Option Exercise | $7.20 | 1,000 | 7,200 | 20,465 | Oct 17, 2017, 06:30 PM |
| RINGO WILLIAM R | Director | Oct 16, 2017 | Sale | $33.70 | 1,000 | 33,700 | 19,465 | Oct 17, 2017, 06:30 PM |
| RINGO WILLIAM R | Director | May 12, 2017 | Sale | $22.00 | 3,461 | 76,142 | 0 | May 16, 2017, 04:31 PM |
| RINGO WILLIAM R | Director | May 10, 2017 | Option Exercise | $23.39 | 1,539 | 35,997 | 23,926 | May 12, 2017, 04:30 PM |
| RINGO WILLIAM R | Director | May 10, 2017 | Option Exercise | $7.20 | 5,000 | 36,000 | 25,465 | May 12, 2017, 04:30 PM |
| Small Derek A | CEO and President | Feb 11, 2016 | Buy | $5.56 | 1,555 | 8,647 | 634,391 | Feb 12, 2016, 04:05 PM |
| Small Derek A | CEO and President | Feb 10, 2016 | Buy | $5.52 | 8,445 | 46,633 | 632,836 | Feb 12, 2016, 04:05 PM |
| ELLISON RUSSELL H | Chief Executive Officer | May 27, 2014 | Buy | $0.92 | 13,000 | 11,960 | 58,000 | May 28, 2014, 05:30 PM |
| ELLISON RUSSELL H | Chief Executive Officer | May 23, 2014 | Buy | $0.91 | 15,000 | 13,603 | 45,000 | May 27, 2014, 09:25 AM |
| ELLISON RUSSELL H | Chief Executive Officer | May 22, 2014 | Buy | $0.90 | 5,000 | 4,500 | 30,000 | May 27, 2014, 09:25 AM |
| BARRETT DAVID JONATHAN | Chief Financial Officer | May 23, 2014 | Buy | $0.88 | 1,000 | 880 | 46,980 | May 27, 2014, 09:12 AM |
| BARRETT DAVID JONATHAN | Chief Financial Officer | May 22, 2014 | Buy | $0.86 | 5,980 | 5,143 | 45,980 | May 27, 2014, 09:12 AM |
| ELLISON RUSSELL H | Chief Executive Officer | May 21, 2014 | Buy | $0.87 | 10,000 | 8,698 | 25,000 | May 22, 2014, 04:36 PM |
| ALTIG ANTHONY E | Director | May 21, 2014 | Option Exercise | $0.88 | 25,000 | 21,900 | 40,000 | May 22, 2014, 04:10 PM |
| BARRETT DAVID JONATHAN | Chief Financial Officer | May 20, 2014 | Buy | $0.88 | 40,000 | 35,200 | 40,000 | May 21, 2014, 09:09 AM |
| ALTIG ANTHONY E | Director | Mar 20, 2013 | Option Exercise | $3.00 | 15,000 | 45,000 | 15,000 | Mar 22, 2013, 07:06 AM |
| ELLISON RUSSELL H | Chief Executive Officer | Feb 05, 2013 | Buy | $2.59 | 5,624 | 14,566 | 15,000 | Feb 06, 2013, 04:08 PM |
| ELLISON RUSSELL H | Chief Executive Officer | Feb 04, 2013 | Buy | $2.52 | 9,376 | 23,628 | 9,376 | Feb 06, 2013, 04:08 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| McHutchison John G | Director | 04/01/2024 | 15,765 |
| White Nicole S | Chief Manufacturing Officer | 04/01/2024 | 2,575 |
| Okazaki Jason A | CEO and President | 04/01/2024 | 4,627 |
| Okazaki Jason A | CEO and President | 03/27/2024 | 5,045 |
| Schornstein Alexander | 10% Owner | 01/17/2024 | 235,195 |
| Schornstein Alexander | 10% Owner | 01/18/2024 | 276,069 |
| Schornstein Alexander | 10% Owner | 11/21/2023 | 66,700 |
| Schornstein Alexander | 10% Owner | 11/20/2023 | 215,400 |
| White Nicole S | Chief Manufacturing Officer | 11/17/2023 | 329 |
| White Nicole S | Chief Manufacturing Officer | 10/03/2023 | 1,504 |
| Delaney William E IV | Chief Scientific Officer | 10/03/2023 | 1,504 |
| Okazaki Jason A | CEO and President | 10/03/2023 | 1,879 |
| Delaney William E IV | Chief Scientific Officer | 08/02/2023 | 10,293 |
| Okazaki Jason A | CEO and President | 08/02/2023 | 12,867 |
| Bjorkquist Jeanette M | Principal Accounting Officer | 07/24/2023 | 900 |
| Delaney William E IV | Chief Scientific Officer | 05/30/2023 | 4,046 |
| McHutchison John G | Director | 05/23/2023 | 27,019 |
| Bjorkquist Jeanette M | Principal Accounting Officer | 05/23/2023 | 285 |
| Delaney William E IV | Chief Scientific Officer | 05/23/2023 | 6,825 |
| Okazaki Jason A | CEO and President | 05/23/2023 | 6,825 |
| McHutchison John G | Director | 03/30/2023 | 12,252 |
| Bjorkquist Jeanette M | Principal Accounting Officer | 03/30/2023 | 637 |
| Delaney William E IV | Chief Scientific Officer | 03/30/2023 | 2,816 |
| Okazaki Jason A | CEO and President | 03/30/2023 | 3,496 |
| Okazaki Jason A | CEO and President | 03/27/2023 | 4,785 |
| McHutchison John G | Chief Executive Officer | 08/08/2022 | 26,200 |
| Samar Michael P. | Chief Financial Officer | 07/25/2022 | 4,479 |
| Delaney William E IV | Chief Scientific Officer | 05/31/2022 | 8,005 |
| Samar Michael P. | Chief Financial Officer | 03/30/2022 | 4,953 |
| Stamm Luisa M | Chief Medical Officer | 03/30/2022 | 2,250 |
| Delaney William E IV | Chief Scientific Officer | 03/30/2022 | 2,250 |
| Okazaki Jason A | Chief Operating Officer | 03/30/2022 | 2,750 |
| McHutchison John G | CEO and President | 03/30/2022 | 10,000 |
| Okazaki Jason A | Chief Operating Officer | 03/28/2022 | 10,363 |
| McHutchison John G | CEO and President | 08/09/2021 | 43,781 |
| Papkoff Jacqueline Sybil | SVP-CSO Microbiome | 12/14/2020 | 7,983 |
| Stamm Luisa M | Chief Medical Officer | 11/09/2020 | 22,404 |
| McHutchison John G | CEO and President | 08/07/2020 | 264,917 |
| Papkoff Jacqueline Sybil | SVP-CSO Microbiome | 03/30/2020 | 17,831 |
| Colonno Richard James | EVP & CSO, Virology Ops | 03/31/2020 | 117,524 |
| Papkoff Jacqueline Sybil | SVP-CSO Microbiome | 12/13/2019 | 30,662 |
| Colonno Richard James | EVP & CSO, Virology Ops | 12/12/2019 | 232,419 |
| Colonno Richard James | EVP & CSO, Virology Ops | 12/12/2019 | 826,578 |
| Lopatin Uri A | Chief Med. Off., VP Res. Dev. | 09/06/2018 | 13,442 |
| Lopatin Uri A | Chief Med. Off., VP Res. Dev. | 09/05/2018 | 609,547 |
| Small Derek A | CEO and President | 07/19/2018 | 99,551 |
| RINGO WILLIAM R | Director | 07/02/2018 | 7,200 |
| RINGO WILLIAM R | Director | 07/02/2018 | 38,503 |
| RINGO WILLIAM R | Director | 06/01/2018 | 7,200 |
| RINGO WILLIAM R | Director | 06/01/2018 | 42,470 |
| RINGO WILLIAM R | Director | 05/01/2018 | 7,200 |
| RINGO WILLIAM R | Director | 05/01/2018 | 43,060 |
| RINGO WILLIAM R | Director | 04/02/2018 | 7,200 |
| RINGO WILLIAM R | Director | 04/02/2018 | 49,320 |
| RINGO WILLIAM R | Director | 03/01/2018 | 7,200 |
| RINGO WILLIAM R | Director | 03/01/2018 | 56,370 |
| RINGO WILLIAM R | Director | 02/01/2018 | 7,200 |
| RINGO WILLIAM R | Director | 02/01/2018 | 46,860 |
| RINGO WILLIAM R | Director | 01/02/2018 | 7,200 |
| RINGO WILLIAM R | Director | 01/02/2018 | 45,040 |
| RINGO WILLIAM R | Director | 12/01/2017 | 7,200 |
| RINGO WILLIAM R | Director | 12/01/2017 | 49,370 |
| RINGO WILLIAM R | Director | 11/01/2017 | 7,200 |
| RINGO WILLIAM R | Director | 11/01/2017 | 29,550 |
| RINGO WILLIAM R | Director | 10/16/2017 | 7,200 |
| RINGO WILLIAM R | Director | 10/16/2017 | 33,700 |
| RINGO WILLIAM R | Director | 05/12/2017 | 76,142 |
| RINGO WILLIAM R | Director | 05/10/2017 | 35,997 |
| RINGO WILLIAM R | Director | 05/10/2017 | 36,000 |
| Small Derek A | CEO and President | 02/11/2016 | 8,647 |
| Small Derek A | CEO and President | 02/10/2016 | 46,633 |
| ELLISON RUSSELL H | Chief Executive Officer | 05/27/2014 | 11,960 |
| ELLISON RUSSELL H | Chief Executive Officer | 05/23/2014 | 13,603 |
| ELLISON RUSSELL H | Chief Executive Officer | 05/22/2014 | 4,500 |
| BARRETT DAVID JONATHAN | Chief Financial Officer | 05/23/2014 | 880 |
| BARRETT DAVID JONATHAN | Chief Financial Officer | 05/22/2014 | 5,143 |
| ELLISON RUSSELL H | Chief Executive Officer | 05/21/2014 | 8,698 |
| ALTIG ANTHONY E | Director | 05/21/2014 | 21,900 |
| BARRETT DAVID JONATHAN | Chief Financial Officer | 05/20/2014 | 35,200 |
| ALTIG ANTHONY E | Director | 03/20/2013 | 45,000 |
| ELLISON RUSSELL H | Chief Executive Officer | 02/05/2013 | 14,566 |
| ELLISON RUSSELL H | Chief Executive Officer | 02/04/2013 | 23,628 |
Load More Insider Transactions
FUNDS WITH A POSITION IN ASSEMBLY BIOSCIENCES INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 947,984 | 0.00002% | -10.79% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 612,006 | 0.00005% | 26.12% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 430,517 | 0.00055% | -12.8% | Other |
CHANGE IN SHARES OUTSTANDING FOR ASSEMBLY BIOSCIENCES INC
STOCK BUYBACKS FOR ASSEMBLY BIOSCIENCES INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2022
-89.02%
5Q
06/30/2022
-88.98%
6Q
03/31/2022
-88.94%
7Q
12/31/2021
-88.16%
8Q
09/30/2021
-88.32%
9Q
06/30/2021
-87.59%
10Q
03/31/2021
-86.59%
11Q
12/31/2020
-85.11%
12Q
09/30/2020
-85.01%
13Q
06/30/2020
-85.73%
14Q
03/31/2020
-84.83%
15Q
12/31/2019
-80.82%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ASSEMBLY BIOSCIENCES INC
LOADING...